{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:45:40Z","timestamp":1790840740830,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtha.2026.06.027","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:55:34Z","timestamp":1782543334000},"page":"3761-3770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A historical review of the biological, semantic and clinical aspects of aspirin resistance"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1546-0774","authenticated-orcid":false,"given":"Pierre","family":"Fontana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Reny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lecompte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.06.027_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2018.10.008","article-title":"The first 3500 years of aspirin history from its roots - A concise summary","volume":"113","author":"Montinari","year":"2019","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jtha.2026.06.027_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(67)91658-3","article-title":"Impaired platelet-connective-tissue reaction in man after aspirin ingestion","volume":"2","author":"Weiss","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.06.027_bib3","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","article-title":"Acetylation of prostaglandin synthase by aspirin","volume":"72","author":"Roth","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jtha.2026.06.027_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.296.6618.320","article-title":"Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration","volume":"296","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jtha.2026.06.027_bib5","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.06.027_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.STR.24.3.345","article-title":"Aspirin response and failure in cerebral infarction","volume":"24","author":"Helgason","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2026.06.027_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2026.06.027_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/376721","article-title":"Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms","volume":"2012","author":"Rocca","year":"2012","journal-title":"Thrombosis"},{"key":"10.1016\/j.jtha.2026.06.027_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/367243a0","article-title":"The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1","volume":"367","author":"Picot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2026.06.027_bib10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(81)91733-5","article-title":"Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis","volume":"1","author":"Hanley","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.06.027_bib11","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110576","article-title":"Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects","volume":"69","author":"Patrignani","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.06.027_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00000441-196609000-00003","article-title":"Salicylates and bleeding: the aspirin tolerance test","volume":"252","author":"Quick","year":"1966","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jtha.2026.06.027_bib13","first-page":"10","article-title":"Aspirin-induced prolongation of the ivy bleeding time. Its diagnostic usefulness","volume":"115","author":"Sahud","year":"1971","journal-title":"Calif Med"},{"key":"10.1016\/j.jtha.2026.06.027_bib14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0049-3848(91)90085-B","article-title":"Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients","volume":"63","author":"Grotemeyer","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.027_bib15","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","article-title":"Development of aspirin resistance in persons with previous ischemic stroke","volume":"25","author":"Helgason","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2026.06.027_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.027_bib17","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/eurheartj\/ehm226","article-title":"A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease","volume":"28","author":"Lordkipanidze","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.06.027_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bcmd.2005.12.017","article-title":"Aspirin \u201cresistance\u201d","volume":"36","author":"Schror","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jtha.2026.06.027_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/09537100120104890","article-title":"Towards a definition of aspirin resistance: A typological approach","volume":"13","author":"Weber","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2026.06.027_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1538-7836.2006.01867.x","article-title":"Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers","volume":"4","author":"Fontana","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1538-7836.2007.02498.x","article-title":"Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection","volume":"5","author":"Cattaneo","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jacc.2005.06.058","article-title":"Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease","volume":"46","author":"Maree","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2026.06.027_bib23","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.STR.0000231683.43347.ec","article-title":"Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers","volume":"37","author":"Cox","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2026.06.027_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.112.117283","article-title":"Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin","volume":"127","author":"Grosser","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.06.027_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jacc.2016.11.050","article-title":"Enteric coating and aspirin nonresponsiveness in patients with type 2 diabetes mellitus","volume":"69","author":"Bhatt","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2026.06.027_bib26","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1055\/s-0040-1714351","article-title":"Patients with essential thrombocythemia may be poor responders to enteric-coated aspirin, but not to plain aspirin","volume":"120","author":"Scavone","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100138","article-title":"Precision antiplatelet therapy","volume":"7","author":"Rocca","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V69.1.180.180","article-title":"Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs","volume":"69","author":"Reilly","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.027_bib29","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/j.1538-7836.2008.03133.x","article-title":"Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2","volume":"6","author":"Armstrong","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11239-020-02334-x","article-title":"Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B(2) and agonist-induced platelet aggregation","volume":"51","author":"Gurbel","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2026.06.027_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2018.01.010","article-title":"Influence of pre-analytical time and temperature conditions on serum thromboxane B(2) levels","volume":"163","author":"van Diemen","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.027_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/09537104.2015.1072147","article-title":"Aspirin response: Differences in serum thromboxane B2 levels between clinical studies","volume":"27","author":"Brun","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2026.06.027_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102623","article-title":"Stability of the thromboxane B(2) biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples","volume":"8","author":"Petrucci","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/jth.14445","article-title":"Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation","volume":"17","author":"Petrucci","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/ehp097","article-title":"COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment","volume":"30","author":"Pulcinelli","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.06.027_bib36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0038-1646320","article-title":"Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins","volume":"68","author":"Winocour","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jprot.2018.09.007","article-title":"A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot study","volume":"192","author":"Finamore","year":"2019","journal-title":"J Proteomics"},{"key":"10.1016\/j.jtha.2026.06.027_bib38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCINTERVENTIONS.110.960187","article-title":"Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease","volume":"4","author":"Capodanno","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2026.06.027_bib39","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3324\/haematol.2022.281388","article-title":"Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?","volume":"108","author":"Cattaneo","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.06.027_bib40","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood-2011-06-359224","article-title":"Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target","volume":"119","author":"Pascale","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.027_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood.2019004596","article-title":"A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia","volume":"136","author":"Rocca","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.06.027_bib42","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management","volume":"95","author":"Tefferi","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.06.027_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s40246-024-00699-1","article-title":"The associations of candidate gene polymorphisms with aspirin resistance in patients with ischemic disease: a meta-analysis","volume":"18","author":"Li","year":"2024","journal-title":"Hum Genomics"},{"key":"10.1016\/j.jtha.2026.06.027_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCGENETICS.111.964627","article-title":"Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes","volume":"6","author":"Lewis","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jtha.2026.06.027_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111816","article-title":"Genetic determinants of on-aspirin platelet reactivity: Focus on the influence of PEAR1","volume":"9","author":"Wurtz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2026.06.027_bib46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jth.13943","article-title":"Multiplate((R)) evaluation of acetylsalicylic acid efficacy in carotid surgery: routine and genetic influencing factors","volume":"16","author":"Roullet","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cts.12438","article-title":"Prospective evaluation of genetic variation in platelet endothelial aggregation receptor 1 reveals aspirin-dependent effects on platelet aggregation pathways","volume":"10","author":"Backman","year":"2017","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jtha.2026.06.027_bib48","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1038\/s41467-021-23470-9","article-title":"Genome sequencing unveils a regulatory landscape of platelet reactivity","volume":"12","author":"Keramati","year":"2021","journal-title":"Nature communications"},{"key":"10.1016\/j.jtha.2026.06.027_bib49","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3324\/haematol.2019.235895","article-title":"Identification of a homozygous recessive variant in PTGS1 resulting in a congenital aspirin-like defect in platelet function","volume":"106","author":"Chan","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.06.027_bib50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0049-3848(93)90164-J","article-title":"Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients","volume":"71","author":"Grotemeyer","year":"1993","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.027_bib51","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis","volume":"167","author":"Snoep","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2026.06.027_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.06.027_bib53","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/archinte.168.5.549","article-title":"Laboratory-defined aspirin resistance and recurrent cardiovascular events","volume":"168","author":"Fontana","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2026.06.027_bib54","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1538-7836.2008.02897.x","article-title":"Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis","volume":"6","author":"Reny","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib55","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1161\/CIRCULATIONAHA.105.596627","article-title":"Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: A 700-patient study of aspirin resistance","volume":"113","author":"Frelinger","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.06.027_bib56","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/CIRCULATIONAHA.109.900589","article-title":"Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization","volume":"120","author":"Frelinger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.06.027_bib57","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1161\/CIRCULATIONAHA.111.085464","article-title":"Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: Results of the Antiplatelet Drug Resistances and Ischemic Events Study","volume":"125","author":"Reny","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.06.027_bib58","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.06.027_bib59","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jamaneurol.2015.0654","article-title":"Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on-treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysm: A randomized clinical trial","volume":"72","author":"Hwang","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jtha.2026.06.027_bib60","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1161\/STROKEAHA.120.032989","article-title":"Effect of adjusted antiplatelet therapy on preventing ischemic events after stenting for intracranial aneurysms","volume":"52","author":"Li","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2026.06.027_bib61","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3174\/ajnr.A7923","article-title":"Effect of platelet function testing guidance on clinical outcomes for patients with intracranial aneurysms undergoing endovascular treatment","volume":"44","author":"Wang","year":"2023","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jtha.2026.06.027_bib62","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1538-7836.2005.01351.x","article-title":"Platelet Physiology Subcommittee of the S, Standardization Committee of the International Society on T, Haemostasis, Working Group on Aspirin R. Aspirin resistance: Position paper of the working group on aspirin resistance","volume":"3","author":"Michelson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib63","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines and the society for cardiovascular angiography and interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.06.027_bib64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/eurheartj\/eht375","article-title":"Working group on thrombosis of the ESC. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention","volume":"35","author":"Aradi","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.06.027_bib65","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.06.027_bib66","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: A report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.06.027_bib67","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2026.06.027_bib68","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/neurintsurg-2014-011357","article-title":"Platelet function inhibitors and platelet function testing in neurointerventional procedures","volume":"6","author":"Gandhi","year":"2014","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.jtha.2026.06.027_bib69","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/jnis-2022-019844","article-title":"Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update","volume":"15","author":"Schirmer","year":"2023","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.jtha.2026.06.027_bib70","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3174\/ajnr.A6814","article-title":"Antiplatelet management for stent-assisted coiling and flow diversion of ruptured intracranial aneurysms: A DELPHI consensus statement","volume":"41","author":"Ospel","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jtha.2026.06.027_bib71","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH11-04-0226","article-title":"Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients","volume":"106","author":"Zufferey","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.027_bib72","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00439-016-1642-1","article-title":"New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach","volume":"135","author":"Zufferey","year":"2016","journal-title":"Human genetics"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:44:13Z","timestamp":1790797453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626004125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":72,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1538783626004125"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.027","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A historical review of the biological, semantic and clinical aspects of aspirin resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}